Patient Perceptions of Artificial Intelligence–Supported Shared Decision-Making in UK Primary Care for Multiple Long-Term Conditions: Qualitative Study - Top-Institutions - MDSpire

Patient Perceptions of Artificial Intelligence–Supported Shared Decision-Making in UK Primary Care for Multiple Long-Term Conditions: Qualitative Study

  • By

  • Charlotte Spurway

  • Sarah Flanagan

  • Jenny Cooper

  • Francesca L Crowe

  • Shamil Haroon

  • Tom Marshall

  • Leah Fitzsimmons

  • Eleanor Hathaway

  • Krishnarajah Nirantharakumar

  • Thomas Jackson

  • Sheila Greenfield

  • Louise Jackson

  • July 3, 2026

  • 0 min

Share

Top Institutions in Family Medicine

Brief introduction explaining scope and methodology.

  • #1

    Stanford Health
    Stanford Health

    Stanford, California

    Key Differentiators

    • Primary Care

  • #2

    University of Exeter
    University of Exeter

    Exeter, England

    Key Differentiators

    • Primary Care

  • #3

    University of Manchester
    University of Manchester

    Manchester, England

    Key Differentiators

    • Primary Care

  • #4

    University of Bristol
    University of Bristol

    Bristol, England

    Key Differentiators

    • Primary Care

  • #5

    University of Southampton
    University of Southampton

    Southampton, England

    Key Differentiators

    • Primary Care

Original Source(s)

Patient Perceptions of Artificial Intelligence–Supported Shared Decision-Making in UK Primary Care for Multiple Long-Term Conditions: Qualitative Study

  • by Charlotte Spurway, Sarah Flanagan, Jenny Cooper, Francesca L Crowe, Shamil Haroon, Tom Marshall, Leah Fitzsimmons, Eleanor Hathaway, Krishnarajah Nirantharakumar, Thomas Jackson, Sheila Greenfield, Louise Jackson

  • July 3, 2026

Related Content

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution Instruments

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.